Dow Up0.59% Nasdaq Up0.75%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
10.50 Down 0.01(0.10%) 4:00PM EDT
|After Hours : 10.44 Down 0.06 (0.57%) 6:24PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 3,802   2,358   1,740   9,487  
Cost of Revenue -   -   -   -  
Gross Profit 3,802   2,358   1,740   9,487  
Operating Expenses
Research Development9,607  8,225  6,404  5,438  
Selling General and Administrative4,347  4,132  4,340  3,283  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (10,153) (10,000) (8,004) 766  
Income from Continuing Operations
Total Other Income/Expenses Net893  (454)(6,464)(34,525)
Earnings Before Interest And Taxes(9,260)(10,454)(14,468)(33,759)
Interest Expense -   -   -   -  
Income Before Tax(9,260)(10,454)(14,468)(33,759)
Income Tax Expense -   -   -   -  
Minority Interest6  9  13  13  
Net Income From Continuing Ops(10,711)(10,821)(14,454)(30,877)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (10,711) (10,821) (15,454) (30,877)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,711) (10,821) (15,454) (30,877)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.